Interview with Kitima Yuthavong, CEO, PREMA Thailand
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones…
Address: 408/85, 19th Floor, Phaholyothin Place Bldg. Phaholyothin Road Samsennai, Phayathai Bangkok 10400,Thailand
Tel: (02) 619-0232
PREMA is a non-profit organization representing members who are research based pharmaceutical companies innovating medicines to combat the previously incurable diseases and to improve on existing treatments.
The Pharmaceutical Research and Manufacturers Association (PReMA) is dedicated to promoting good health and quality of life for the Thai people and to support the advancement of public health systems through the research and development of innovative medicines. PReMA also supports the rights to choice by the people and the healthcare professionals to high quality medicines that best meet their needs.
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones…
Servier Thailand’s general manager discusses the company’s competitive role in Thailand despite market challenges, the company’s ability to remain innovative and successful regardless of Thailand’s changing policies and Servier’s unique…
The Thailand Institute of Scientific and Technological Research’s (TISTR) governor shares the institute’s role in facilitating R&D, the use of herbal medicine in Thailand and the future growth of R&D…
Daiichi Sankyo Thailand’s managing director explains the Thai subsidiary’s success under his leadership, Thailand’s untapped potential as a regional economic center in Southeast Asia and his company’s role in providing high quality…
PReMA’s CEO discusses the association’s role within the industry as an organization that is improving the healthcare system in Thailand and on helping companies in the pharmaceutical industry bring innovation and…
As one of the figureheads of the BIOTECh industry in Thailand, could you introduce your background to our readers? I was trained as a biochemist in Thailand, and did my…
Pharmaceutical Executive, highlighting the milestones in the company development since you took over five years ago? Unilab is the biggest pharmaceutical company in the Philippines, with a market share of…
Indochina’s biggest pharmaceutical market (US$ 4 billion, 66 million population, <5 percent of GDP spent on healthcare) has quickly matured over the past years due to the implementation of…
You moved from the post of President for Sanofi Pasteur in Korea to President of Sanofi Pasteur in Thailand 1,5 years back. What have been the milestones so far and…
Dr. Seeto, this is your first head of country position for AZ! Looking back at your first year-and-a-month, what have been the highlights and the key lessons learnt? Firstly, leading…
Asia is rapidly becoming a new frontier for drug development as Western companies seek to develop and register their products in Asia, while emerging Asian companies seek new capabilities to…
Dr. Witit, when we interviewed your predecessor in 2006, we talked about the vital role and leading position GPO plays in the Thai pharmaceutical industry and the company’s investments in…
‘When markets are inefficient, relationships are important. When markets are more efficient, relationships become less important because the markets become more systematic, professional, and objective in the way they operate,’…
See our Cookie Privacy Policy Here
